Syntopix Group PLC

AIM-listed Syntopix group aims to leverage the antimicrobial expertise of its scientific founders at the University of Leeds to become a world-class drug development company providing clinical solutions for important dermatological diseases.

The Institute of Pharmaceutical Innovation

University of Bradford

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Archive

More from Scrip